| 摘要 |
A pharmaceutical composition comprising tiotropium bromide, formoterol fumarate and mometasone furoate, and its use in the symptomatic and/or prophylactic treatment of respiratory diseases especially asthma, allergic rhinitis, chronic obstructive pulmonary disease |
